Gold prices steady ahead of Fed decision; weekly weakness noted
NEW YORK - Colgate-Palmolive Company (NYSE:CL), a consumer goods giant with a market capitalization of $74.6 billion and impressive gross profit margins of nearly 61%, has announced a series of executive leadership changes set to take effect on June 16, 2025, as part of its strategy to bolster global operations and achieve its growth objectives. According to InvestingPro analysis, the company currently trades slightly above its Fair Value, with 16 analysts recently revising their earnings expectations downward for the upcoming period.
Shane Grant, 50, will assume the role of Chief Operating Officer, Americas, a newly established position at Colgate-Palmolive. Grant’s prior experience includes a tenure as Group Deputy CEO, CEO Americas, and EVP Dairy, Plant-Based and Global Sales at Group Danone, as well as nearly two decades at The Coca-Cola Company in various leadership roles.
Panagiotis Tsourapas, 60, has been appointed Chief Operating Officer, overseeing Europe, Asia Pacific, Africa Eurasia, Skin Health & Global Customer Development. Tsourapas has a long-standing career with Colgate-Palmolive, having held positions in Customer Development, Marketing, and senior leadership.
John Hazlin, 55, will take on the responsibility of Chief Growth Officer. In this capacity, Hazlin will lead the 2030 Strategic Plan, focusing on transformation and development across various global functions. Hazlin currently serves as President of the company’s Hill’s Pet Nutrition business.
Stanley Sutula III, 59, the Chief Financial Officer, will expand his remit to include strategic oversight of Global Information Technology and Mergers & Acquisitions, leveraging his extensive experience in transformational roles.
Prabha Parameswaran, 66, has been named Vice Chair. In this role, Parameswaran will focus on innovation, omni demand generation, and the integration of AI throughout the organization, while continuing to lead sustainability and social impact strategies until her retirement on October 1, 2025.
These leadership appointments were announced by Noel Wallace, Chairman, President, and Chief Executive Officer of Colgate-Palmolive, who emphasized the importance of building capabilities and refining the organizational structure to achieve the company’s ambitious growth goals. With a moderate debt level and strong cash flows sufficient to cover interest payments, the company maintains a solid financial foundation. Discover more detailed insights about Colgate-Palmolive’s financial health and growth potential with InvestingPro, which offers 12 additional exclusive ProTips and comprehensive analysis.
Colgate-Palmolive is known for its portfolio of products across Oral Care, Personal Care, Home Care, and Pet Nutrition, selling in over 200 countries and territories. The company also actively promotes sustainability and community wellbeing through various initiatives, including the Colgate Bright Smiles, Bright Futures program. With a remarkable track record of raising dividends for 35 consecutive years and maintaining payments for 55 years, the company demonstrates strong financial discipline and shareholder commitment. InvestingPro’s detailed Research Report provides comprehensive analysis of the company’s market position and future prospects among 1,400+ top US stocks.
This leadership restructuring is based on a press release statement from Colgate-Palmolive Company.
In other recent news, Colgate-Palmolive Company reported its financial results for the first quarter of 2025, revealing a slight miss on earnings per share (EPS) but exceeding revenue forecasts. The company posted an EPS of $0.85, falling short of the expected $0.87, while revenue reached $4.91 billion, surpassing the forecast of $4.89 billion. Goldman Sachs maintained its Buy rating on Colgate-Palmolive with a price target of $106.00, citing the strong performance of the Hill’s Pet Nutrition segment as a key growth driver. Piper Sandler also reiterated its Overweight rating and $109.00 price target, highlighting the company’s stable business practices and shareholder value focus.
Colgate-Palmolive’s Hill’s Pet Nutrition is projected by Goldman Sachs to continue its trajectory of mid-single-digit organic sales growth, supported by category expansion and market share gains. The company is also investing in product innovation and marketing to enhance its market presence. Furthermore, Colgate-Palmolive expects tariffs to add $200 million in costs for 2025, and it is actively working on mitigation strategies. The company plans to exit the private label business by the third quarter of 2025.
Overall, Colgate-Palmolive is focusing on innovation and market expansion, particularly in its pet nutrition segment, to drive growth amid challenging market conditions. The company has also invested $2 billion in the U.S. supply chain over the past five years to enhance its operational flexibility. Both Piper Sandler and Goldman Sachs view Colgate-Palmolive as a strong investment, citing its geographic strengths and commitment to shareholder returns.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.